What if one small valve could change the lives of millions suffering from chronic venous insufficiency? In this episode, we sit down with Rob Berman, CEO of EnVVeno Medical, to explore how his team is disrupting vascular care with the groundbreaking VenoValve—the first surgical solution for deep vein reflux. Rob shares how this innovation is restoring quality of life, slashing wound care costs, and opening doors for future transcatheter therapies like ENVE. You'll hear hard-earned lessons on leadership, FDA navigation, and raising $135 million to bring first-in-class technology to market. From the OR to investor boardrooms, Rob’s journey is packed with grit, insight, and purpose. If you’re innovating in medtech, this one’s a masterclass.